Hannah Deresiewicz
Investor Relations Contact bij FORTY SEVEN, INC.
Actieve functies van Hannah Deresiewicz
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FORTY SEVEN, INC. | Investor Relations Contact | - | - |
| KALA BIO, INC. | Investor Relations Contact | - | - |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-06-2013 | - |
Loopbaan van Hannah Deresiewicz
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KALA BIO, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
- Beurs
- Insiders
- Hannah Deresiewicz
- Ervaring
